Beacon Angels

Type

Angel Group/Syndicate

Status

Active

Location

Boston, United States

Total investments

29

Average round size

2M

Portfolio companies

25

Rounds per year

1.61

Follow on index

0.14

Exits

6

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologyDrug DeliverySoftwareAnalyticsInformation TechnologyHealth CareMedical DeviceMedicalMarketingTherapeutics

Summary

Beacon Angels is the famous VC, which was founded in 2006. The venture was found in North America in United States. The main department of described VC is located in the Boston.

The fund was created by Dan Von Kohorn, Lex Kelso, William Swiggart.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Beacon Angels, startups are often financed by Cherrystone Angel Group, Maine Angels, Keiretsu Capital. The meaningful sponsors for the fund in investment in the same round are LaunchPad Venture Group, Boston Harbor Angels, North Country Angels. In the next rounds fund is usually obtained by Cherrystone Angel Group, Maine Angels, PROOF.VC.

The fund has no exact preference in some founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Copiun, Siamab Therapeutics, GateRocket. We can highlight the next thriving fund investment areas, such as Medical, Marketing.

The increased amount of exits for fund were in 2018. The typical startup value when the investment from Beacon Angels is 1-5 millions dollars. This Beacon Angels works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2012. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 investment rounds annually.

Show more

Investor highlights

Stage focus
Seed
Geo focus
Check size
50K — 400K

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
29
Lead investments
0
Exits
6
Rounds per year
1.61
Follow on index
0.14
Investments by industry
  • Health Care (12)
  • Biotechnology (11)
  • Therapeutics (7)
  • Software (7)
  • Information Technology (6)
  • Show 43 more
Investments by region
  • United States (29)
Peak activity year
2012

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
20M
Group Appearance index
0.90
Avg. company exit year
8
Avg. multiplicator
8.17

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
GreenCircle 01 Dec 2020 E-Commerce, Rental, Delivery, Marketplace, Delivery Service, E-Commerce Platforms, GreenTech, Sharing Economy Seed 147K Berlin, Berlin, Germany
Pykus Therapeutics 01 Jan 2018 Health Care, Medical, Therapeutics Seed United States, Massachusetts, Boston
RBI medical 02 Apr 2024 Seed 2M United States, Massachusetts, Worcester

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.